Heat shock proteins refine the danger theory

Immunology

Volumn 99, Issue 3, 2000, Pages 334-337

  Todryk, S M ^a   Melcher, A A ^b   Dalgleish, A G ^a   Vile, R G ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL DEATH; IMMUNE RESPONSE; PRIORITY JOURNAL; STRESS; TISSUE INJURY;

APOPTOSIS; AUTOIMMUNITY; BACTERIAL INFECTIONS; CELL DEATH; HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, CELLULAR; NECROSIS; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 0034009643     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00002.x     Document Type: Article

References (28)

1. 1. Janeway C.A. Jr (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13, 11.
2. 2. Matzinger P. (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12, 991.
3. 3. Kaufmann S.H. (1990) Heat shock proteins and the immune response. Immunol Today 11, 129.
4. 4. Van Eden W., Van Der Zee R., Paul A.G., Prakken B.J., Wendling U., Anderton S.M. & Wauben M.H. (1998) Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today 19, 303.
5. 5. Barrios C., Lussow A.R., Vanembden J. et al. (1992) Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guerin priming. Eur J Immunol 22, 1365.
6. 6. Birk O.S., Gur S.L., Elias D. et al. (1999) The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci USA 96, 5159.
7. 7. Gething M.J. & Sambrook J. (1992) Protein folding in the cell. Nature 355, 33.
8. 8. Srivastava P.K. (1993) Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv Cancer Res 62, 153.
9. 9. Srivastava P.K., Menoret A., Basu S., Binder R.J. & McQuade K.L. (1998) Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8, 657.
10. 10. Udono H., Levey D.L. & Srivastava P.K. (1994) Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc Natl Acad Sci USA 9, 3077.
11. 11. Suto R. & Srivastava P.K. (1995) A mechanism for the specific immunogenicity of heat shockprotein-chaperoned peptides. Science 269, 1585.
12. 12. Chandawarkar R.Y., Wagh M.S. & Srivastava P.K. (1999) The dual nature of specific immunological activity of tumor-derived gp96 preparations. J Exp Med 189, 1437.
13. 13. Ciupitu A.M., Petersson M., O'Donnell C.L. et al. (1998) Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med 187, 685.
14. 14. Arnold D., Faath S., Rammensee H. & Schild H. (1995) Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 182, 885.
15. 15. Blachere N.E., Li Z., Chandawarkar R.Y. et al. (1997) Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med 186, 1315.
16. 16. Arnold-Schild D., Hanau D., Spehner D. et al. (1999) Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 162, 3757.
17. 17. Melcher A., Gough M., Todryk S. & Vile R. (1999) Apoptosis or necrosis for tumor immunotherapy - what's in a name? J Mol Med in press.
18. 18. Morimoto R.I. & Santoro M.G. (1998) Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nature Biotechnol 16, 833.
19. 19. Melcher A., Todryk S., Hardwick N., Ford M., Jacobson M. & Vile R.G. (1998) Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nature Med 4, 581.
20. 20. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R. & Girkontaite I. (1997) Immunosuppressive effects of apoptotic cells. Nature 390, 350.
21. 21. Albert M.L.B., Sauter & Bhardwaj N. (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86.
22. 22. Melcher A., Murphy S. & Vile R. (1999) Heat shock protein expression in target cells infected with low levels of replication-competent virus contributes to the immunogenicity of adenoviral vectors. Hum Gene Ther 10, 1431.
23. 23. Rizzo M., Alevy Y.G., Sundaresan S. et al. (1998) Increased expression of HDJ-2 (heat shock protein 40) and heat shock protein 70 in biopsy specimens of transplanted human lungs. J Heart Lung Transplant 17, 241.
24. 24. Schett G., Redlich K., Xu Q. et al. (1998) Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. J Clin Invest 102, 302.
25. 25. Chen W., Syldath U., Bellmann K., Burkart V. & Kolb H. (1999) Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 162, 3212.
26. 26. Breloer M., Fleischer B. & Von Bonin A. (1999) In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins. J Immunol 162, 3141.
27. 27. Todryk S., Melcher A.A., Hardwick N. et al (1999) Heat shock protein 70 induced during tumor cell killing induces Th1cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol 163, 1398.
28. 28. Fucus E.J. & Matzinger P. (1996) Is cancer dangerous to the immune system? Semin Immunol 8, 271.